Jasper Bos
Equibles does not estimate personal net worth.
Get an email with a short summary when enGene Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ENGN alertsAbout Jasper Bos
enGene Therapeutics Inc. reported in an 8-K filed July 8, 2025 that Jasper Bos resigned as director, effective July 7, 2025. enGene Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at enGene Therapeutics Inc. includes Ron Cooper (CEO and Board Member), Ronald H. W. Cooper (CEO and Board Member), Ronald H.W. Cooper (CEO and Board Member) and 7 others.
“On July 7, 2025, Jasper Bos resigned as a director of the Board of Directors (the "Board") of enGene Holdings Inc. (the "Company"), including as a member of any committee of the Board.”
Affiliation history
-
enGene Therapeutics Inc. (ENGN)
SEC 8-K
Current2023-10-31–present
-
Start not stated–2025-07-07
Company network
Leadership on record at enGene Therapeutics Inc.
- Ron Cooper CEO, Board Member
- Ronald H. W. Cooper CEO, Board Member
- Ronald H.W. Cooper CEO, Board Member
- Ryan Daws CFO
- Alex Nichols COO
- Alexander Nichols COO
- Dr. Alex Nichols COO
- Anthony Cheung CTO
- Joan Connolly CTO
- Dr. William Grossman Board Member